Picture of Oncorus logo

ONCR Oncorus Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Oncorus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-18-30.7-48.3-64.8-77.4
Depreciation
Non-Cash Items-0.0370.758136.577.04
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.0361.67-2.886.425.06
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-17.2-27.2-36.8-49.8-61.7
Capital Expenditures-0.291-0.977-1.06-9.55-19.9
Purchase of Fixed Assets
Other Investing Cash Flow Items-23.2-13.1
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-0.291-0.977-1.06-32.7-33
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities24.553.412653.619.7
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash7.0525.287.9-29-75